Meet Our Experts Please select a topic: Chemistry, Manufacturing and Control AuditBiopharmaceuticalsCell LinesCMO & CRO Selection and ManagementDue DiligenceFormulation DevelopmentGMPInterim ManagementIn Vitro DiagnosticsIVDLife-cycle ManagementProgram & Project EvaluationQualified PersonQuality Control and AssuranceR&D StrategiesRadiopharmaceuticalsRegulatory CMCRisk ManagementScientific Writing Non-clinical Research and Development Contract Research ServiceDisease ModelsDrug DiscoveryDue DiligenceGrant ApplicationImaging Agents & MethodologyInterim ManagementOncologyPharmacodynamicsPharmacokineticsPharmacologyPreclinical DevelopmentR&D StrategiesREACHScientific MarketingScientific WritingTarget IdentificationTest Laboratory ServiceToxicology Clinical Development BiomarkersBiostatisticsBusiness DevelopmentClinical Development Phase IClinical Development Phase II-IIIClinical OperationsClinical Study ManagementDrug SafetyDue DiligenceIn Vitro DiagnosticsIVDHealth Economics and Market AccessImagingLicensingInterim ManagementKnowledge ManagementLife-cycle ManagementMedical AffairsMedical DevicesPharmacogeneticsPK-PDQuality Risk ManagementR&D StrategiesSubmission SupportTranslational MedicineVendor managementVendor selection Regulatory Affairs and Compliance Conformity AssessmentCTAsDrug SafetyDue DiligenceIn Vitro DiagnosticsIVDGxPsLife-cycle ManagementMedical DevicesPharmacovigilanceQuality AssuranceQuality SystemsRegulatory AffairsRegulatory StrategiesScientific Advice ProceduresSOPsSubmissions Business Strategy & Development, Intellectual Property and Corporate Design Agreements & ContractsBusiness DevelopmentBusiness RepresentationCommercial StrategyCommercial OperationsCommunicationCorporate DesignCorporate FinanceFunding OpportunitiesGeneral ManagementIntellectual PropertyInterim ManagementLawLicensingM&AsMarket ResearchMarketingSalesSocial MediaTrademarks Michael Firgens Regulatory Affairs, Global Development Strategy, Interim Management Dirk Groenewegen Cell & Gene Therapy , Business Development , Venture Building , Public and Private Funding Siglinde Dürr Quality Management, Auditing, CMC Sabine Pilari Pharmacometrics & PK/PD Modeling Jörg Täubel Clinical Pharmacology Cardiac Safety Expert Michael Zimmermann Medical Devices – Clinical and Regulatory Affairs Johannes Lampe Clinical Development, R&D Strategies Michael Hildebrand CMC, Preclinical Development Alexander Krannich Biostats GmbH provides expert biostatistics and clinical study support services Frank S. Zollmann Clinical Development, Preclinical Development, R&D Strategies Katja Wosikowski Nonclinical Drug Development, Translational Medicine Hans Lindner CMC, Pharmaceutical Development Heiner Zindel CMC Anke Maaßen In Vitro Diagnostics – RA, QM, QA, CMC Astrid Schott Clinical Development, Interim Management, R&D Strategies Christian Nagelstrasser Corporate Design Jens Hoffmann Preclinical Development, R&D Strategies Thomas Fink Corporate Finance Christian Hucke Expert for Project Management, Clinical Operations and Quality Risk Management Christian Wolf Clinical Development, Interim Management, Medical Affairs Daniel Sehrt Clinical Development, R&D Strategies Moritz Hillgenberg Commercial Assessment, Market Research Wolf-Stefan Richter Clinical Development, R&D Strategies Marco Swantusch Clinical-/Commercial GxP-Consulting, Interim Leadership, Auditing, Quality Management